Published in Immunopharmacology on December 01, 1981
Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49
Virulence factors of Bordetella pertussis. Annu Rev Microbiol (1986) 6.41
Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun (1983) 5.03
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Giardiasis in the mouse: an animal model. Gastroenterology (1976) 4.47
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis (1984) 3.48
A chromosome bin map of 16,000 expressed sequence tag loci and distribution of genes among the three genomes of polyploid wheat. Genetics (2004) 3.37
Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem (1983) 3.11
Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature (1975) 2.92
Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun (1988) 2.69
Nucleotide sequence and characterization of a repetitive DNA element from the genome of Bordetella pertussis with characteristics of an insertion sequence. J Gen Microbiol (1988) 2.46
A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med (1975) 2.19
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils. J Exp Med (1977) 2.06
Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J Bacteriol (1991) 1.90
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science (1994) 1.78
Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J Biol Chem (1983) 1.74
Lassa fever in Britain: an imported case. Br Med J (1973) 1.72
Acquired resistance to infection in an animal model of giardiasis. J Immunol (1976) 1.70
Eosinophils and resistance to Trichinella spiralis. J Exp Med (1977) 1.68
N-Acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. I. Partial purification and relation to amoebic virulence in vitro. J Infect Dis (1985) 1.67
ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J Biol Chem (1984) 1.67
Tropical medicine. BMJ (2000) 1.67
Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg (1974) 1.61
Toxins of Vibrio cholerae and Escherichia coli stimulate adenyl cyclase in rat fat cells. Nature (1974) 1.58
Experimental infection of mongrel dogs with Giardia lamblia cysts and cultured trophozoites. J Infect Dis (1982) 1.56
Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein. J Immunol (1989) 1.45
Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J Immunol (1987) 1.45
Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg (1980) 1.43
Thymus dependency of host resistance to Giardia muris infection: studies in nude mice. J Immunol (1978) 1.42
Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein. Mol Microbiol (1991) 1.42
Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells. J Biol Chem (1983) 1.41
Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J Clin Invest (1976) 1.41
Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J Biol Chem (1989) 1.39
Species specificity of Bordetella adherence to human and animal ciliated respiratory epithelial cells. Infect Immun (1983) 1.36
Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni. J Immunol (1981) 1.35
Analysis of expressed sequence tag loci on wheat chromosome group 4. Genetics (2004) 1.33
Rhodopsin-enhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase. J Biol Chem (1984) 1.33
Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine. Infect Immun (1987) 1.31
Dynamics of antigen and mitogen-induced responses in murine schistosomiasis japonica: in vitro comparison between hepatic granulomas and splenic cells. J Immunol (1981) 1.31
Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani. Science (1982) 1.30
Chromosome bin map of expressed sequence tags in homoeologous group 1 of hexaploid wheat and homoeology with rice and Arabidopsis. Genetics (2004) 1.29
Giardia lamblia infection of suckling mice. J Infect Dis (1983) 1.29
Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma. J Immunol (1974) 1.29
Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity. J Immunol (1975) 1.27
Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon. N Engl J Med (1974) 1.27
Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol (1978) 1.26
Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases. J Infect Dis (1977) 1.25
Drugs five years later: praziquantel. Ann Intern Med (1989) 1.23
Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. J Clin Invest (1981) 1.22
Algorithms in the Diagnosis and Management of Exotic Diseases. ii. Giardiasis. J Infect Dis (1975) 1.21
In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum-activated macrophages. J Immunol (1979) 1.21
Pertussis toxin or phorbol 12-myristate 13-acetate can distinguish between epidermal growth factor- and angiotensin-stimulated signals in hepatocytes. Proc Natl Acad Sci U S A (1986) 1.20
Adoptive transfer of modulation of granuloma formation and hepatosplenic disease in murine schistosomiasis japonica by serum from chronically infected animals. J Immunol (1982) 1.20
Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg (1988) 1.19
Morbidity in Schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya. Am J Trop Med Hyg (1976) 1.19
Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect Immun (1999) 1.19
Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ (1976) 1.19
Adenylate cyclase toxin from Bordetella pertussis produces ion conductance across artificial lipid bilayers in a calcium- and polarity-dependent manner. J Biol Chem (1994) 1.18
Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases. Ann Intern Med (1985) 1.18
Rapid, accurate quantification of schistosome eggs via nuclepore filters. J Parasitol (1976) 1.18
Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med (1975) 1.18
Antileishmanial activity of chlorpromazine. Antimicrob Agents Chemother (1984) 1.17
Niclosamide therapy for tapeworm infections. Ann Intern Med (1985) 1.17
Chemotherapy-based control of schistosomiasis haematobia. 3. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya. Trans R Soc Trop Med Hyg (1990) 1.17
Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii. Nature (1976) 1.16
Antieosinophil serum and the kinetics of eosinophilia in Schistosomiasis mansoni. J Exp Med (1975) 1.15
Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. J Clin Microbiol (1984) 1.15
Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis. FEBS Lett (1991) 1.15
Genetic differences in BCG-induced resistance to Schistosoma mansoni are not controlled by genes within the major histocompatibility complex of the mouse. J Immunol (1978) 1.14
Role of Ni in coupling angiotensin receptors to inhibition of adenylate cyclase in hepatocytes. J Biol Chem (1985) 1.13
NIH conference. Cyclic nucleotides: mediators of bacterial toxin action in disease. Ann Intern Med (1984) 1.13
Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice. J Clin Invest (1977) 1.12
Role of arginase in killing of schistosomula of Schistosoma mansoni. J Exp Med (1980) 1.12
Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg (2001) 1.12
Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11
Production of a rabbit antimouse eosinophil serum with no cross-reactivity to neutrophils. J Exp Med (1973) 1.11
Schistosomiasis haematobia in coast province Kenya. Relationship between egg output and morbidity. Am J Trop Med Hyg (1979) 1.11
Hemolytic, but not cell-invasive activity, of adenylate cyclase toxin is selectively affected by differential fatty-acylation in Escherichia coli. J Biol Chem (1995) 1.10
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10
Does enteropathogenic Escherichia coli produce heat-labile enterotoxin, heat-stable enterotoxins a or b, or cholera toxin A subunits? Infect Immun (1984) 1.10
Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun (2000) 1.09
Genetic studies of the molecular basis of whooping cough. Dev Biol Stand (1985) 1.09
Soluble antigens and antibodies in sera from baboons infected with Schistosoma mansoni. J Immunol (1976) 1.08
Open-access endoscopy: are age-based guidelines justified? An audit of experience of 1000 open-access endoscopies at a district general hospital. Endoscopy (2003) 1.08
Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis. Mol Microbiol (2004) 1.07
Bordetella extracytoplasmic adenylate cyclase: actions as a bacterial toxin. Dev Biol Stand (1985) 1.06
Regulation of Bordetella pertussis extracytoplasmic adenylate cyclase. Adv Cyclic Nucleotide Res (1978) 1.06
Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J Immunol (1997) 1.06
Algorithms in the diagnosis and management of exotic diseases. xxii. ascariasis and toxocariasis. J Infect Dis (1977) 1.06
Effector mechanism of host resistance in murine giardiasis: specific IgG and IgA cell-mediated toxicity. J Immunol (1985) 1.06
Killing of schistosomula of Schistosoma mansoni by normal human monocytes. J Immunol (1979) 1.06
ADP-ribosylation of transducin by pertussis toxin. J Biol Chem (1985) 1.05
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
New sesquiterpene alpha-methylene lactones from the Egyptian plant Jasonia candicans. J Nat Prod (1993) 1.04